Radiofrequency ablation following first-line transarterial chemoembolization for patients with unresectable hepatocellular carcinoma beyond the Milan criteria

BACKGROUND: Recent studies suggest that a combination of radiofrequency ablation (RFA) and transarterial chemoembolization (TACE) may have theoretical advantages over TACE alone for treatment of hepatocellular carcinoma (HCC). The purpose of this study was to evaluate the effectiveness and safety of...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Lan, Yin, Xin, Gan, Yu-hong, Zhang, Bo-heng, Zhang, Ju-bo, Chen, Yi, Xie, Xiao-ying, Ge, Ning-lin, Wang, Yan-hong, Ye, Sheng-long, Ren, Zheng-gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890612/
https://www.ncbi.nlm.nih.gov/pubmed/24410841
http://dx.doi.org/10.1186/1471-230X-14-11

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890612/
https://www.ncbi.nlm.nih.gov/pubmed/24410841
http://dx.doi.org/10.1186/1471-230X-14-11

Ejemplares similares